TraceLink, the SaaS platform for tracking and tracing pharmaceuticals, has today announced the close of a $51.5 million Series C financing led by Goldman Sachs Growth Equity. Existing investors, such as FirstMark Capital, Volition Capital, and F-Prime Capital, also participated in the round. As part of the deal, Goldman’s Jason Kreuziger is joining TraceLink’s board of… Read More
from TechCrunch https://techcrunch.com/2016/11/30/tracelink-helping-the-pharma-industry-trace-and-track-drugs-lands-51-5m-from-goldman-sachs/?ncid=rss
via IFTTT
0 Comments